Competitive landscape

Early mapping of the competitive landscape and unmet clinical needs is critical for identifying risks and opportunities. These insights empower you to craft a data-driven target product profile (TPP) and design clinical trials and real-world studies that highlight the asset’s unique strengths. With expertise in literature reviews and indirect treatment comparisons, we help you position your product, monitor key comparators, and gain early insights into comparative effectiveness.

Evidence gap analyses

If you are unsure whether your clinical program captures the full value of your technology, evidence gap analysis can reduce that uncertainty. By comparing existing and planned evidence with your value claims and HTA requirements, we help identify gaps and develop a strategic roadmap to successful market access.

HTA readiness

HTA requirements should be addressed well before reimbursement submissions - ideally before pivotal trial design. We help you anticipate and avoid future HTA challenges through targeted reviews of guidelines and past appraisals, JCA scoping simulations, and preparation of briefing materials for national early advice and Joint Scientific Consultations.

‍Advisory board management

Advisory boards are a key way to gather early, independent feedback from leading clinicians and HEOR experts. We recruit well-balanced boards, facilitate focused discussions, and ensure alignment between internal and external stakeholders to inform your evidence generation strategy across key markets.

Economic value

Early economic models quantify potential cost-effectiveness and commercial viability, highlight value drivers and evidence gaps, and let you stress-test assumptions with stakeholders. Our bespoke models help you make confident investment decisions and ensure your clinical program and reimbursement strategy are fully aligned with market needs.

‍

‍

‍